Literature DB >> 6249510

Injections and paralytic poliomyelitis in tropical Africa.

B Guyer, A A Bisong, J Gould, M Brigaud, M Aymard.   

Abstract

A case-control study was conducted in Yaoundé, United Republic of Cameroon, to evaluate the hypothesis that intramuscular inoculations predisposed young children to paralysis if they were later exposed to poliomyelitis virus. Thirty-three cases with lower motor neuron disease and 66 neighbourhood controls were studied. Poliovirus was isolated from 39% of the paralytic cases but from only 18% of the comparison group. Controls were more likely to have had serological evidence of previous exposure to all three poliovirus types while most of the paralytic cases had been exposed to a poliovirus for the first time. Two-thirds of the paralytic cases but only 11% of the comparison group had been ill, visited a medical facility, and received multiple injections, primarily with quinine and penicillin, in the month prior to the onset of poliomyelitis. There was a strong temporal relationship between these injections and the onset of paralysis. The increased relative risks (15 and 32, respectively) of paralysis associated with inoculations in the two weeks immediately prior to onset of disease were felt to represent the treatment of symptoms related to poliomyelitis. However, the increased relative risks (13 and 27, respectively) three and four weeks prior to onset were felt to be consistent with the hypothesis that intramuscular injections provoked paralysis. Overestimation of this measure of the effect because of bias in the control group is discussed.

Entities:  

Mesh:

Year:  1980        PMID: 6249510      PMCID: PMC2395791     

Source DB:  PubMed          Journal:  Bull World Health Organ        ISSN: 0042-9686            Impact factor:   9.408


  8 in total

1.  Poliomyelitis in Nigeria.

Authors:  W R COLLIS; O RANSOME-KUTI; M E TAYLOR; L E BAKER
Journal:  West Afr Med J       Date:  1961-08

2.  Viremia in experimental poliomyelitis. II. Viremia and the mechanism of the provoking effect of injections or trauma.

Authors:  D BODIAN
Journal:  Am J Hyg       Date:  1954-11

3.  The incubation period of poliomyelitis.

Authors:  P E SARTWELL
Journal:  Am J Public Health Nations Health       Date:  1952-11

4.  Poliomyelitis in relation to intramuscular injections of quinine and other drugs.

Authors:  W F TOWNSEND-COLES; G M FINDLAY
Journal:  Trans R Soc Trop Med Hyg       Date:  1953-01       Impact factor: 2.184

5.  Provocation poliomyelitis and entry of poliovirus to the CNS.

Authors:  H V Wyatt
Journal:  Med Hypotheses       Date:  1976 Nov-Dec       Impact factor: 1.538

6.  A programme of multiple-antigen childhood immunization in Yaoundé, Cameroon: first-year evaluation, 1975-1976.

Authors:  B Guyer; S Atangana
Journal:  Bull World Health Organ       Date:  1977       Impact factor: 9.408

7.  A plan to protect children from disease. The immunization programme in Yaoundé.

Authors:  S Atangana; B Guyer
Journal:  WHO Chron       Date:  1977-12

8.  Outside Europe. Is poliomyelitis a serious problem in developing countries?--the Danfa experience.

Authors:  D D Nicholas; J H Kratzer; S Ofosu-Amaah; D W Belcher
Journal:  Br Med J       Date:  1977-04-16
  8 in total
  4 in total

1.  Comparison of three neurotropic viruses reveals differences in viral dissemination to the central nervous system.

Authors:  Lauren N Luethy; Andrea K Erickson; Palmy R Jesudhasan; Mine Ikizler; Terence S Dermody; Julie K Pfeiffer
Journal:  Virology       Date:  2015-10-16       Impact factor: 3.616

Review 2.  Innate host barriers to viral trafficking and population diversity: lessons learned from poliovirus.

Authors:  Julie K Pfeiffer
Journal:  Adv Virus Res       Date:  2010       Impact factor: 9.937

3.  Paralytic poliomyelitis in children under 6 years in Pondicherry: a community survey.

Authors:  M B Soudarssanane; S B Rotti; D K Srinivasa; G Ramalingam
Journal:  J Epidemiol Community Health       Date:  1993-06       Impact factor: 3.710

4.  Mechanism of injury-provoked poliomyelitis.

Authors:  M Gromeier; E Wimmer
Journal:  J Virol       Date:  1998-06       Impact factor: 5.103

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.